Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Westlake Chemical Partners (WLKP) Liabilities and Shareholders Equity (2016 - 2026)

Westlake Chemical Partners filings provide 13 years of Liabilities and Shareholders Equity readings, the most recent being $1.3 billion for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 2.44% to $1.3 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.2 billion, a 0.79% increase, with the full-year FY2025 number at $1.3 billion, down 2.44% from a year prior.
  • Liabilities and Shareholders Equity hit $1.3 billion in Q4 2025 for Westlake Chemical Partners, down from $1.3 billion in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.5 billion in Q4 2021 to a low of $1.3 billion in Q4 2025.
  • Median Liabilities and Shareholders Equity over the past 5 years was $1.3 billion (2023), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: grew 9.16% in 2021 and later fell 8.65% in 2023.
  • Westlake Chemical Partners' Liabilities and Shareholders Equity stood at $1.5 billion in 2021, then decreased by 7.34% to $1.4 billion in 2022, then fell by 4.02% to $1.3 billion in 2023, then decreased by 2.19% to $1.3 billion in 2024, then decreased by 2.44% to $1.3 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025) per Business Quant data.